Stockreport

Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Rallybio Corporation  (RLYB) 
PDF - Rallybio to Receive Funding for FNAIT Awareness Initiative and Equity Investment from Johnson & Johnson - NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (N [Read more]